The European Hematology Association (EHA)

Welcome
Introduction to CAR T cell therapy
Current clinical landscape for CAR T in Europe
Clinical and regulatory implementation of CAR T in Europe
Future developments
EHA Topics-in-Focus: Immunotherapy

The European Hematology Association (EHA)

Menu

Webinars

« Back

Schüssler-Lenz - CAR-T cells - a regulatory view from the EMA Committee for Advanced Therapies – Friday, session 9

EHA Executive Office - Koninginnegracht 12b, 2514 AA - The Hague, The Netherlands
Phone: +31 (0)70 3020 099 Email: [email protected] KvK-number 24334797

© Copyright 2017 - European Hematology Association All rights reserved.
Web design: Loyals